Education
About Us
Working with TipRanks
Follow Us
Pfizer Inc (GB:0Q1N)
:0Q1N
Total Valuation
Pfizer has a market cap or net worth of $130.76B. The enterprise value is $126.67B.
Market Cap$130.76B
Enterprise Value$126.67B
Share Statistics
Pfizer has 5,685,365,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,685,365,700
Owned by Insiders0.03%
Owned by Institutions0.86%
Financial Efficiency
Pfizer’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.45%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.45%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee785.52K
Profits Per Employee99.40K
Employee Count81,000
Asset Turnover0.30
Inventory Turnover1.51
Valuation Ratios
The current PE Ratio of Pfizer is 18.71. Pfizer’s PEG ratio is -7.60.
PE Ratio18.71
PS Ratio0.00
PB Ratio1.44
Price to Fair Value1.70
Price to FCF13.41
Price to Operating Cash Flow10.91
PEG Ratio-7.60
Income Statement
In the last 12 months, Pfizer had revenue of 63.63B and earned 8.03B in profits. Earnings per share was 1.42.
Revenue63.63B
Gross Profit47.21B
Operating Income14.94B
Pretax Income8.02B
Net Income8.03B
EBITDA18.13B
Earnings Per Share (EPS)1.42
Cash Flow
In the last 12 months, operating cash flow was 11.65B and capital expenditures -2.21B, giving a free cash flow of 9.45B billion.
Operating Cash Flow11.65B
Free Cash Flow9.45B
Free Cash Flow per Share1.66
Dividends & Yields
Pfizer pays an annual dividend of $1.698, resulting in a dividend yield of 7.4%
Dividend Per Share$1.698
Dividend Yield7.4%
Payout Ratio52.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-14.31%
50-Day Moving Average23.74
200-Day Moving Average25.77
Relative Strength Index (RSI)45.18
Average Volume (3m)448.94K
Important Dates
Pfizer upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateApr 29, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMay 09, 2025
Financial Position
Pfizer as a current ratio of 1.17, with Debt / Equity ratio of 0.00%
Current Ratio1.17
Quick Ratio0.92
Debt to Market Cap0.42
Net Debt to EBITDA3.45
Interest Coverage Ratio4.83
Taxes
In the past 12 months, Pfizer has paid -28.00M in taxes.
Income Tax-28.00M
Effective Tax Rate>-0.01
Enterprise Valuation
Pfizer EV to EBITDA ratio is 11.74, with an EV/FCF ratio of 21.64.
EV to Sales3.35
EV to EBITDA11.74
EV to Free Cash Flow21.64
EV to Operating Cash Flow16.70
Balance Sheet
Pfizer has $20.48B in cash and marketable securities with $0.00 in debt, giving a net cash position of -$20.48B billion.
Cash & Marketable Securities$20.48B
Total Debt$0.00
Net Cash-$20.48B
Net Cash Per Share-$3.60
Tangible Book Value Per Share-$6.26
Margins
Gross margin is 67.39%, with operating margin of 23.48%, and net profit margin of 12.62%.
Gross Margin67.39%
Operating Margin23.48%
Pretax Margin12.61%
Net Profit Margin12.62%
EBITDA Margin28.49%
EBIT Margin17.47%
Analyst Forecast
The average price target for Pfizer is $27.94, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$27.94
Price Target Upside21.90% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast―
EPS Growth Forecast―